The work that Beam Therapeutics is executing is just phenomenal and its involvement with gene therapy and editing can make it a large-stakes prospect. As the next 50 % in the 12 months begins, biotech breakthrough shares are emerging as good choices for investors. This post highlights 3 biotech shares within the verge of important approvals that m